SetSet

SetSet Supports Psychedelic Integration The world's first clinician-backed consumer platform for safe, accessible psychedelic education and integration. And we are women-forward. Why does this matter? Psychedelics are shown to improve outcomes in conditions for which women are more likely to be diagnosed: PTSD, depression, anxiety, and disordered eating. Yet as of 2023, only 29% of participants in studies of psilocybin and 24% of participants in studies of MDMA were women. Furthermore, women are more likely to report challenging psychedelic experiences with hormones possibly contributing. SetSet aims to provide evidence-based information for postive, longer lasting outcomes.